Author(s): Tejaswini S. Madane, Shivanjali S. Lakhapate, Omkar A. Devade, Laximikant M. Purane, Vivekkumar K. Redasani

Email(s): mtejaswinimpharm@gmail.com

DOI: 10.52711/2321-5836.2025.00014   

Address: Tejaswini S. Madane*, Shivanjali S. Lakhapate, Omkar A. Devade, Laximikant M. Purane, Vivekkumar K. Redasani
Department of Pharmacology, YSPM’s Yashoda Technical Campus, Satara 415 011, Maharashtra, India.
*Corresponding Author

Published In:   Volume - 17,      Issue - 2,     Year - 2025


ABSTRACT:
Throughout the course of psychopathology's history, the term melancholia has been assigned various meanings. Initially, it was primarily associated with affective disorders such as fear and sadness, as well as abnormal beliefs. During Hippocrates' time, melancholia was predominantly viewed in terms of its affective component. From then until the eighteenth century, there were differing opinions among authors, with both affective disorders and abnormal beliefs being considered important aspects of melancholia. However, in the eighteenth to nineteenth centuries, particularly during Pinel's era, melancholia became exclusively synonymous with abnormal beliefs. As the nineteenth century transitioned into the twentieth century, the affective component regained prominence as the primary characteristic of melancholia. Melancholic depression is a chronic condition that is often characterized by recurring episodes. Melancholia, a syndrome with a rich historical background and unique psychopathological characteristics, is distinguished from major depression by the DSM-IV specifiers and partially outlined in the International Classification of Diseases [ICD -10th edition].


Cite this article:
Tejaswini S. Madane, Shivanjali S. Lakhapate, Omkar A. Devade, Laximikant M. Purane, Vivekkumar K. Redasani. Review on Melancholic Disorder. Research Journal of Pharmacology and Pharmacodynamics.2025;17(2):89-4. doi: 10.52711/2321-5836.2025.00014

Cite(Electronic):
Tejaswini S. Madane, Shivanjali S. Lakhapate, Omkar A. Devade, Laximikant M. Purane, Vivekkumar K. Redasani. Review on Melancholic Disorder. Research Journal of Pharmacology and Pharmacodynamics.2025;17(2):89-4. doi: 10.52711/2321-5836.2025.00014   Available on: https://rjppd.org/AbstractView.aspx?PID=2025-17-2-1


REFERENCE:
1.    Kessler, R.C.  Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Archives of General Psychiatry. 1994; 51(1): 8. doi:10.1001/archpsyc.1994.03950010008002.
2.    Cohen, N.L. (1992) ‘psychiatric disorders in America the epidemiologic catchment area study—edited by Lee N. Robins, Phd and Darrel A. Regier, M.D., M.P.H.; New York, Free Press, 1991, 449 pages, $49.95’, Psychiatric Services, 43(3), pp. 289–289. doi:10.1176/ps.43.3.289.
3.    Jansson, Å. (2020) ‘Melancholia and depression’, Oxford Research Encyclopedia of Psychology doi:10.1093/acrefore/9780190236557.013.623.
4.    Svenaeus, F. Diagnosing mental disorders and saving the normal.  Medicine, Health Care and Philosophy, 2013; 17(2): 241–244. doi:10.1007/s11019-013-9529-6.
5.    Barsky, A.J., Orav, E.J. and Bates, D.W. Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Archives of General Psychiatry. 2005; 62(8): p. 903. doi:10.1001/archpsyc.62.8.903.
6.    Regier, D.A. The de facto US mental and addictive disorders service system. Archives of General Psychiatry. 1993; 50(2): 85. Doi:10.1001/archpsyc.1993.01820140007001
7.    Klinkman, M.S. Competing demands in psychosocial care. General Hospital Psychiatry. 1997; 19(2): 98–111. doi:10.1016/s0163-8343(96)00145-4.
8.    Gerber, P.D.et al. Recognition of depression by internists in primary care. Journal of General Internal Medicine. 1989; 4(1): 7–13.doi:10.1007/bf02596483.
9.    Pincus, H.A. et al. Prescribing trends in psychotropic medications. JAMA. 1998; 279(7): 526. doi:10.1001/jama.279.7.526.
10.    Simon, G.E. Recognition, management, and outcomes of depression in primary care. Archives of Family Medicine. 1995; 4(2):. 99–105. doi:10.1001/archfami.4.2.99.
11.    Cardemil, E.V.  Depression. Encyclopedia of the Human Brain. 2002: 101–113. doi:10.1016/b0-12-227210-2/00119-9.
12.    Bourin M. History of depression through the ages. Arch Depress Anxiety. 2020; 6(1): 010-018.
13.    Kessler, R.C.  Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Archives of General Psychiatry. 1994; 51(1): 8. doi:10.1001/archpsyc.1994.03950010008002.
14.    Bourin, M.  Bipolar disorder is now a more common disease to be treated. Theranostics of Brain Spine & Neural Disorders. 2017; 1(3). doi:10.19080/tbsnd.2017.01.555564.
15.    Michel, B. Postpartum depression: An overview. Archives of Depression and Anxiety. 2018; 65–67. doi:10.17352/2455-5460.000035.
16.    Benazzi, F.  Various forms of depression. Dialogues in Clinical Neuroscience. 2006; 8(2): 151–161. doi:10.31887/dcns.2006.8.2/fbenazzi.
17.    Benazzi, F.  Family history validation of a definition of mixed depression.  Comprehensive Psychiatry. 2005; 46(3): 159-166 doi: 10.1016/j.comppsych.2004.07.034.
18.    Akiskal, H.S. Switching from unipolar to bipolar II, Archives of General Psychiatry. 1995b; 52(2): 114. doi:10.1001/archpsyc.1995.03950140032004.
19.    Angst, J. et al. Toward validation of atypical depression in the community: Results of the zurich cohort study.  Journal of Affective Disorders. 2002; 72(2): 125–138. doi:10.1016/s0165-0327(02)00169-6.
20.    Parker, G. et al. The nature of bipolar depression: Implications for the definition of melancholia. Journal of Affective Disorders, 2000; 59(3): 217–224. doi:10.1016/s0165-0327(99)00144-5.
21.    Angst, J., Sellar, R. and Merikangas, K.R.  Depressive Spectrum diagnoses. Comprehensive Psychiatry. 2000; 41(2): 39–47. doi:10.1016/s0010-440x(00)80007-3.
22.    Bos, G.  Commentary on hippocrates aphorisms: Third hebrew translation (anonymous)Maimonides Commentary on Hippocrates. Aphorisms. 2019; 1: 513–607. doi:10.1163/9789004412880_007.
23.    Jackson, W.A.  A short guide to humoral medicine. Trends in Pharmacological Sciences. 2001; 22(9): 487–489. doi:10.1016/s0165-6147(00)01804-6.
24.    Juruena, M.F. et al. Estudos Latino-Americanos Sobre melancolia: UM transtorno do humor Melhor Definido para o Cid-11. Revista Brasileira de Psiquiatria, 2011; 33(suppl 1). doi:10.1590/s1516-44462011000500005.
25.    Telles-Correia, D. and Marques, J.G. Melancholia before the twentieth century Fear and sorrow or partial in sanity. Frontiers Psychology. 2015; 6. doi:10.3389/fpsyg201500081.
26.    Galen. On the natural faculties. Digital Loeb Classical Library. 1916b doi: 10.4159/dlcl.galen-natural_faculties.1916.
27.    Barclay, K. and Soyer, F. André du Laurens (1558–1609), a discourse of the preseruation of the sight: Of melancholike diseases; of rheumes, and of old age. Emotions in Europe. 2021: 266–274. doi:10.4324/9781003175384-48.
28.    Bright, T. (1940) A treatise of melancholie [Preprint]. doi:10.7312/brig90166.
29.    Burton, R. (1621) ‘The anatomy of melancholy’, The Anatomy of Melancholy, Vol. 1: Text, p. lxi–lxi. doi:10.1093/oseo/instance.00006619.
30.    Cullen, W. (1793). A Synopsis of Methodical Nosology in which the Genera of Disorders are Particularly Defined, and the Species Added with the Synonimous of those from Sauvage, trans. H. Wikins. Philadelphia: Parry Hall.
31.    Esquirol, E.  Art. mental maladies. A treatise on insanity. The American Journal of the Medical Sciences. 1845; 19(1): 161. doi:10.1097/00000441-184507000-00020.
32.    Shorter, E. (1997) ‘The history of mental symptoms: Descriptive psychopathology since the nineteenth century. by G. E. Berrios. (pp. 565.) Cambridge University Press: Cambridge. 1996.’, PsychologicalMedicine,27(4), pp.979982.doi:10.1017/s0033291797225274.
33.    Nöbbelin, L. et al. Incidence of melancholic depression by age of onset and gender in the Lundby Population, 1947–1997.  European Archives of Psychiatry and Clinical Neuroscience. 2022; 273(5): 1163–1173. doi:10.1007/s00406-022-01506-5.
34.    O, T., M, M. and Gunten A, Von. Phenomenological understanding of behavioural and psychological symptoms of dementia: A clinical case presenting howls and shouting. the melancholic type and phenomenology of separation. Journal of Depression & Anxiety. 2017: 6(4). doi:10.4172/2167-1044.1000290.
35.    Telles-Correia, D. et al. Psychosocial predictors of adherence after liver transplant in a single transplant center in Portugal.  Progress in Transplantation. 2012; 22(1): 91–94. doi:10.7182/pit2012569
36.    Gold, P.W. and Chrousos, G.P. Melancholic and atypical subtypes of depression represent distinct pathophysiological entities: Crh, neural circuits, and the diathesis for anxiety and depression. Molecular Psychiatry. 2013; 18(6): 632–634. doi:10.1038/mp.2013.5.
37.    Khan, A.Y. et al.  Clinical and demographic factors associated with DSM-IV melancholic depression. Annals of Clinical Psychiatry. 2006; 18(2): 91–98. doi:10.1080/10401230600614496.
38.    Rush AJ, Fava M, Wisniewski SR, Lavori PW, Trivedi MH, Sackeim HA, Thase ME, Nierenberg AA, Quitkin FM, KashnerTM, Kupfer DJ, Rosenbaum JF, Alpert J, Stewart JW, McGrath PJ, Biggs MM, Shores-Wilson K, Lebowitz BD, Ritz L, Niederehe G. Sequenced treatment alternatives to relieve depression (STAR): rationale and design. Control Clin Trials. 2004; 25:119–142).
39.    Sadeghi, R., Ghandehari Alavijeh, M. and Raeisi Shahraki, H. The role of social support and socioeconomic factors in the prediction of depression among first-year undergraduate students. Depression Research and Treatment. 2023: 1–6. doi:10.1155/2023/3993304.
40.    Spanemberg L, Caldieraro M, Arrua Vares E, Wollenhaupt de Aguiar B, Yuri Kawamoto S, Parker G, et al. biological differences between melancholic and nonmelancholic depression subtyped by the core measure. Neuropsychiatric Disease and Treatment. 2014 Aug; 1523. doi:10.2147/ndt. s66504
41.    Burt VK, Quezada V. Mood disorder in women: Focus on reproductive psychiatry in the 21st century. Can J Clin Pharmacol. 2009; 16(1): e6-14.
42.    Smith, M.  The New Black: Mourning, Melancholia and depression the new black: Mourning, melancholia and depression leader Darian Penguin. Mental Health Practice. 2010; 13(10): 8–8. doi:10.7748/mhp.13.10.8. s12.
43.    HomeWomen's Health Postpartum Health 2018 Latest Statistics of Postpartum Depression Occurrence rate; https://www.checkpregnancy.com/2018-statistics-postpartum-depression-occurrence-rate/
44.    Gordon Parker, M. D.  An Update on Melancholia. 2017; 34(1): 34
45.    Shashi rai, Abhishek pathak etal; Postpartum psychiatric disorder; Early diagnosis and management; Indian Journal of Psychiatry. 57(6): 216-221
46.    Spanemberg, L. et al. (2014) ‘Biological differences between melancholic and nonmelancholic depression subtyped by the core measure’, Neuropsychiatric Disease and Treatment, p. 1523. doi:10.2147/ndt. s66504.
47.    Irfan Naveen and Badar Ahmed, Determinants and pattern of postpartum psychological disorders in Hazata decision of Pakistan; 2002; 6(7); 7.
48.    Schnyer, R.N. and Allen, J.J. (2001) ‘Depression defined: Symptoms, epidemiology, etiology, and treatment’, Acupuncture in the Treatment of Depression, pp. 8–30. doi:10.1016/b978-0-443-07131-7.50009-2.
49.    Shridevi D., S. Anuchithra etal; Impact of Child Birth Preparation on AntenatalDepression; Asian.J. Nur.Edu and Research.  2014; 4(4): 436-442.
50.    Fava, M.  Somatic symptoms, depression, and antidepressant treatment. The Journal of Clinical Psychiatry. 2002; 63(4): 305–307. doi:10.4088/jcp. v63n0406.
51.    R. Naganandini. Effectiveness of Structured Stress Management, Module on Stress of Primi Mothers EarlyPostnatal period in a selected Private Hospital, Salem, Tamil Nadu. Asian. J. Nur. Edu and Research.  2012; 2(4): 220-221.
52.    McArthur, R.A. and Borsini, F.  Preface: What do you mean by “Translational research”? an enquiry through animal and translational models for CNS drug discovery: Psychiatric disorders. Animal and Translational Models for CNS Drug Discovery. 2008: xvii–xxxviii. doi:10.1016/b978-0-12-373861-5.00032-1.
53.    Kavitha Rajagopal. V, Leethyal; Prevalence of postnatal depression among postnatal mothers; Asian. J. Nur. Edu and Research. 2012; 2(1): 33
54.    Coryell, W.  The facets of melancholia. Acta Psychiatrica Scandinavica. 2007; 115(s433): 31–36. doi:10.1111/j.1600-0447.2007.00960. x.
55.    Smit HJ, Gaffan EA, Rogers PJ. Methylxanthines are the psycho-pharmacologically active constituents of chocolate. Psychopharmacology (Berl) 2004; 176: 412-419.
56.    Brown, W.A. Treatment response in melancholia. Acta Psychiatrica Scandinavica. 2007; 115(s433): 125–129. doi:10.1111/j.1600-0447.2007.00970. x.
57.    Kendler KS, Myers J, O Gardner C. Caffeine intake, toxicity and dependence and lifetime risk for psychiatric and substance use disorders: an epidemiologic and co-twin control analysis. Psychol Med. 2006; 36; 1717-1725.
58.    Lewis, G. DSM-IV. diagnostic and Statistical Manual of Mental Disorders, 4th EDN. by the American Psychiatric Association. APA: Washington, DC.1994. Psychological Medicine. 1996; 26(3): 651–652.
59.    Smith AP (2002) Effects of caffeine on human behaviour. Food Chem Toxicol 40, 1243–1255
60.    Carey, C. (2015) ‘DSM-5® guidebook: The essential companion to the Diagnostic and statistical manual of mental disorders. 5th EDN. edited by Donald W. Black and Jon E. Grant (567 pp., ISBN 9781585624652). American Psychiatric Association Publishing: Arlington, Virginia, 2014. Irish Journal of Psychological Medicine, 33(2), pp. 133–134. doi:10.1017/ipm.2015.42.
61.    Parker G, Hadzi-Pavlovic D, Mitchell P, Hickie I, Wilhelm K, Brodaty H, Boyce P, Roy K. Psychosocial risk factors distinguishing melancholic and nonmelancholic depression: a comparison of six systems. Psychiatry Res. 1991; 39: 211–226
62.    Peselow, E.D. et al.  Sociotropy and autonomy: Relationship to antidepressant drug treatment response and endogenousonendogenous dichotomy. Journal of Abnormal Psychology. 1992; 101(3): 479–486. doi:10.1037//0021-843x.101.3.479.
63.    Egan, K.J.  In response to article by Perry et al. The Clinical Journal of Pain. 1994; 10(1); 82–83. doi:10.1097/00002508-199403000-00014.
64.    Imel, Z.E. et al.  A meta-analysis of psychotherapy and medication in unipolar depression and dysthymia. Journal of Affective Disorders. 2008; 110(3); 197–206. doi: 10.1016/j.jad.2008.03.018.
65.    Fink MD, M.  What is electroconvulsive therapy? Electroconvulsive Therapy. 2010 doi:10.1093/oso/9780195365740.003.0005.

Recomonded Articles:

Research Journal of Pharmacology and Pharmacodynamics (RJPPD) is an international, peer-reviewed journal....... Read more >>>

RNI: Not Available                     
DOI: 10.5958 2321-5836 

Journal Policies & Information




Recent Articles




Tags